Proactive Investors - Run By Investors For Investors

Dyadic International disrupting the bio world with their C-1 technology

Dyadic International Inc (OTCMKTS:DYAI) Chief Commercial Officer Matthew Jones sat down with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The Jupiter, Florida, company is focusing on leveraging the patented C1 expression system to help bring vaccines and drugs to market faster.

View full DYAI profile View Profile

Dyadic International Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use